Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Intercept Pharmaceuticals Company Profile (NASDAQ:ICPT)

Consensus Ratings for Intercept Pharmaceuticals (NASDAQ:ICPT) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 14 Buy Rating(s)
Consensus Rating:Buy (Score: 2.72)
Consensus Price Target: $365.67 (133.46% upside)

Current Analysts' Coverage Summary for Intercept Pharmaceuticals (NASDAQ:ICPT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/19/2014Citigroup Inc.Lower Price TargetBuy$693.00 -> $475.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014Janney Montgomery ScottInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
12/18/2014Sterne AgeeInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
12/15/2014Bank of AmericaReiterated RatingBuy$188.00ViewTweet This Rating  Share This Rating on StockTwits
12/4/2014Robert W. BairdInitiated CoverageOutperform$258.00ViewTweet This Rating  Share This Rating on StockTwits
12/3/2014FBR Capital MarketsLower Price TargetUnderperform$125.00 -> $99.00ViewTweet This Rating  Share This Rating on StockTwits
11/11/2014NomuraReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
11/7/2014Leerink SwannDowngradeOutperform -> Market Perform$445.00 -> $191.00ViewTweet This Rating  Share This Rating on StockTwits
11/4/2014Summer StreetReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
10/7/2014JMP SecuritiesInitiated CoverageOutperform$500.00ViewTweet This Rating  Share This Rating on StockTwits
9/5/2014Cowen and CompanyInitiated CoverageOutperform$420.00ViewTweet This Rating  Share This Rating on StockTwits
8/14/2014TheStreetUpgradeHoldViewTweet This Rating  Share This Rating on StockTwits
8/12/2014RBC CapitalBoost Price TargetOutperform$425.00 -> $500.00ViewTweet This Rating  Share This Rating on StockTwits
8/12/2014Deutsche BankUpgradeOutperform$395.00 -> $500.00ViewTweet This Rating  Share This Rating on StockTwits
7/2/2014Goldman SachsInitiated CoverageNeutral$265.00ViewTweet This Rating  Share This Rating on StockTwits
5/8/2014OppenheimerLower Price TargetOutperform$525.00 -> $499.00ViewTweet This Rating  Share This Rating on StockTwits
4/14/2014Needham & Company LLCReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
2/10/2014WedbushBoost Price Target$449.00 -> $493.00ViewTweet This Rating  Share This Rating on StockTwits
1/13/2014BMO Capital MarketsReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/20/2012 forward)